A fitness instructor named Kelsey Ellis records a brief video for Instagram on a gloomy Vancouver morning. Her leggings are lightly stained with chalk from the pull-up bar behind her as she works out in a bright studio. The lighting is poor, and the camera angle is informal. In the video, she uses her hands to swat away hypothetical insults like “diet culture,” “SkinnyTok,” and “what I eat in a day.”
It’s a little show that is half defense and half joke. As you watch it, you get the impression that something more profound is going on beneath the humor.
| Topic | Key Information |
|---|---|
| Subject | Cultural conflict between GLP-1 weight-loss drugs and the body positivity movement |
| Key Medications | Ozempic, Wegovy, Mounjaro |
| Drug Class | GLP-1 receptor agonists (glucagon-like peptide-1) |
| Original Purpose | Treatment for type 2 diabetes |
| New Use | Medical weight loss and appetite regulation |
| Weight Loss Results | Often 10–20% of body weight in clinical trials |
| Cultural Impact | Influencers, celebrities, and everyday users adopting GLP-1s |
| Movement Roots | Fat activism and anti-discrimination campaigns from the 1960s |
| Current Debate | Body autonomy vs. fat acceptance principles |
| Reference | Triage Method |
Because a new force emerged just when body positivity seemed to be at its peak—when plus-size models walked major runways and cellulite was featured in popular fashion campaigns. Ozempic belongs to a class of medications called GLP-1 receptor agonists. Mounjaro Wegovy.
These drugs were first created to treat diabetes. During clinical trials, doctors noticed something intriguing: patients were losing a significant amount of weight, frequently more than 10 or 15 percent of their body mass. The mechanism was biological rather than motivational: GLP-1 medications reduce what many users refer to as “food noise” by imitating a hormone that controls appetite.
The outcomes may be transformative for those who battle obesity. However, culture seldom follows a clear path. Additionally, a movement that has spent decades advocating for the radical idea that all bodies deserve dignity is clashing awkwardly with the widespread use of these drugs.
Instagram was not the starting point of the body positivity movement. Its origins can be traced back to fat activism in the 1960s and 1970s, when supporters opposed discrimination in public places, healthcare systems, and workplaces. The early activists did not advocate for society to embrace obesity. They were asking for basic decency.
By the early 2010s, body positivity had become a popular cultural concept thanks to websites like Instagram and Tumblr. In their advertising, companies like Dove highlighted a variety of body types. Once thought to be exclusively for sample-size bodies, plus-size models started to appear on magazine covers. The culture changed for an instant.
It was difficult to ignore how relieved many people were to see bodies that looked like their own when scrolling through those feeds back then. stretch marks. soft stomachs. actual thighs. Then came the medications for losing weight.
The shift has been subtle but noticeable. Influencers who previously made a living promoting fat acceptance are now sharing pictures of themselves with smaller waistlines and thinner faces. They frequently fail to provide an explanation. However, speculation quickly takes over comment sections. “Are you using Ozempic?” The question is now practically standard.
Some followers have an emotional response that goes beyond simple curiosity. Online conversations sometimes reveal a feeling of betrayal. Critics question why there is a rush to make them smaller now that technology is available if the message was that “all bodies are worthy.”
That question might oversimplify the circumstances. Bodies also bear physical burdens, such as metabolic diseases, diabetes, and joint pain. The choice to use medication to lessen those burdens can feel less like betrayal and more like relief for those who have larger bodies.
However, there is actual cultural tension. Once opposing weight-focused health narratives, the movement is now facing drugs intended specifically to alter body size. Some activists contend that by rebranding historical pressures in clinical terms, this merely medicalizes diet culture.
Others have a different perspective. They contend that self-acceptance and the use of medication to enhance health are compatible. It’s not necessary to reject your previous body in order to choose change.
The tone of this online debate is frequently conflicted rather than antagonistic. Influencers talk about feeling uneasy and curious. Followers talk about wondering if the cultural advancements of the past ten years are subtly reversing as they scroll through feeds full of shrinking bodies. And perhaps it is. Or perhaps the movement is just changing.
The story is further complicated by the larger wellness sector. Nowadays, pharmaceutical companies aggressively promote GLP-1 drugs, sometimes employing imagery that resembles body-positive advertisements: happy plus-size individuals, cozy lighting, and statements about feeling good about your body. It’s hard to miss the irony.
Critics refer to this as “medicalized weight stigma,” arguing that the message is still the same despite the packaging’s gentler appearance: your body is acceptable, but it would still be preferable to be smaller.
Millions of people are still looking for these drugs, though. They are effective, not just because of cultural messaging. And that may be the most nuanced reality of the entire discussion.
Decades of shame and unattainable beauty standards were contested by the body positivity movement. Many people were able to break free from cycles of self-criticism and chronic dieting thanks to it. It’s likely that this cultural change had a greater impact than critics sometimes realize. However, biology has not vanished.
GLP-1 drugs are located right at the nexus of identity and physiology, raising difficult questions. Can someone choose to lose weight and still believe in body acceptance? Can a resistance-based movement change to accommodate new medical opportunities? It’s still not clear.
It seems as though the culture is undergoing a quiet renegotiation as one observes the discussion taking place on social media, in comment sections, and in therapy offices. Not exactly giving up on body positivity. but reevaluating its meaning.
Because movements built around the previous limitations frequently have to reconsider themselves when technology suddenly makes something easier, whether it’s coding with AI or losing weight with medication. The political nature of bodies has not ceased. All they’ve done is start a new chapter.